Balyasny Asset Management
MPT

Balyasny Asset Management’s Medical Properties Trust MPT Stock Holding History

Balyasny Asset Management’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-256,500
Closed -$1.28M – 3279
2025
Q4 		$1.28M Buy
256,500
+71,200
+38% +$371K ﹤0.01% 2074
2025
Q3 		$939K Buy
185,300
+28,000
+18% +$123K ﹤0.01% 2142
2025
Q2 		$678K Buy
+157,300
New +$777K ﹤0.01% 2185
2025
Q1 		– Sell
-19,200
Closed -$75.8K – 3117
2024
Q4 		$75.8K Hold
19,200
– – ﹤0.01% 2622
2024
Q3 		$112K Sell
19,200
-23,500
-55% -$116K ﹤0.01% 2627
2024
Q2 		$184K Buy
+42,700
New +$205K ﹤0.01% 2350

Other funds holding MPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Balyasny Asset Management's MPT Position: Q1 2026 in Review

Balyasny Asset Management increased its Medical Properties Trust (MPT) stake by 321% in Q1 2026, buying an estimated $2.21M and bringing the position to 556,374 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Balyasny Asset Management first reported a position in MPT in Q3 2015 and has held it in 31 quarters since. The position peaked at $84.3M in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Balyasny Asset Management held 556,374 shares of Medical Properties Trust worth $2.58M as of Q1 2026.
  • Balyasny Asset Management bought 424,312 Medical Properties Trust shares in Q1 2026, an estimated $2.21M.
  • Medical Properties Trust made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1675 holding.
  • Balyasny Asset Management first reported a position in Medical Properties Trust in Q3 2015 and has held it in 31 quarters since.
  • Balyasny Asset Management's Medical Properties Trust position peaked at $84.3M in Q4 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.